Literature DB >> 16436303

Another side of genomics: synthetic biology as a means for the exploitation of whole-genome sequence information.

Peer Stähler1, Markus Beier, Xiaolian Gao, Jörg D Hoheisel.   

Abstract

The successful completion of the Human Genome Project and other sequencing projects opened the door for another quantum jump in science advancement. The most important public sequence databases are doubling in size every 18 months. By revealing the genetic program of many organisms, these efforts endow biologists with the ability to study the basic information of life in toto as an initial step toward a comprehensive understanding of the complexity of entire organisms. We review the area of synthetic biology, defined as the making and use of biosystems founded on the chemical synthesis of the coding DNA (and potentially RNA). The recent developments discussed here introduce a rich source of oligonucleotides to the field: in situ synthesised microarrays, which in fact represent nothing else but matrix nucleic acid synthesisers. With this new way of producing the oligonucleotides used in the making of synthetic genes in a very cost-effective manner, the field of synthetic biology can be expected to change dramatically in the next decade. Synthetic genes will then be the tools of choice to obtain any sequence at any time in any laboratory.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16436303     DOI: 10.1016/j.jbiotec.2005.12.011

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  4 in total

1.  DMSO and betaine greatly improve amplification of GC-rich constructs in de novo synthesis.

Authors:  Michael A Jensen; Marilyn Fukushima; Ronald W Davis
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

2.  Microfluidic Reactor Array Device for Massively Parallel In-situ Synthesis of Oligonucleotides.

Authors:  Onnop Srivannavit; Mayurachat Gulari; Zhishan Hua; Xiaolian Gao; Xiaochuan Zhou; Ailing Hong; Tiecheng Zhou; Erdogan Gulari
Journal:  Sens Actuators B Chem       Date:  2009-07       Impact factor: 7.460

3.  A synthetic luxCDABE gene cluster optimized for expression in high-GC bacteria.

Authors:  Arryn Craney; Tobias Hohenauer; Ye Xu; Naveen Kumar Navani; Yingfu Li; Justin Nodwell
Journal:  Nucleic Acids Res       Date:  2007-03-01       Impact factor: 16.971

4.  A multi-target, non-infectious and clonable artificial positive control for routine PCR-based assays.

Authors:  Donna Ria J Caasi; Mohammad Arif; Mark Payton; Ulrich Melcher; Louise Winder; Francisco M Ochoa-Corona
Journal:  J Microbiol Methods       Date:  2013-09-05       Impact factor: 2.363

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.